Clinical Trial Update: Phase II Trial of Silymarin for Patients With Chronic Hepatitis C Who Have Failed Conventional Antiviral Treatment [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating silymarin for chronic hepatitis C in patients who failed conventional antiviral therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Chronic Hepatitis C | Phase 2 | Status: COMPLETED